Skip to main content
Boston ScientificEarnings

Boston Scientific announces results for third quarter 2026

Source: Autobound Signal API · 115 signals tracked for Boston Scientific · updated

Get Boston Scientific's live signals in Claude or ChatGPT, or by API

AskWhat changed at Boston Scientific this week? Use Autobound signals for bostonscientific.com.

What happened

Boston Scientific Corporation reported GAAP net income of $582 million for the third quarter of 2026.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

MARLBOROUGH, Mass., Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported, operational 1 and organic 2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $582 million or $0.40 per share (EPS), compared to $755 million or $0.51 per share a year ago, and achieved adjusted 3 EPS of $0.73 for the period, compared to $0.75 a year ago. "This has been a challenging year for Boston Scientific and I'm proud of how our global teams have responded, particularly to the cybersecurity incident, working with urgency and resilience to restore operations and continue supporting customers and patients," said Mike Mahoney, chairman and chief executive officer, Boston Scientific. "As we move forward, I remain confident in our long-term strategy, fueled by our dedicated talent, differentiated portfolio and strong pipeline of meaningful innovation." Third quarter financial results and recent developments: 1. Operational net sales growth excludes the impact of foreign currency fluctuations. 2. Organic net sales growth excludes the impact of foreign currency fluctuations and net sales attributable to certain acquisitions and divestitures for which there are less than a full period of...

Keep reading with a free account

The rest of this article, and every signal for Boston Scientific, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Earnings

What this signalsEarnings results often set the next budget cycle.

Amount named
$582M
Location
Marlborough, Massachusetts, United States

The full record

From the Signal API record

Numbers

Amount named in the story
$582M

Details

Ticker
NYSE:BSX

Extraction

Confidence
95%
Detected
Oct 28, 2026
signal_type
news
signal_subtype
has_earnings

Use this data

Get every earnings signal for Boston Scientific and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”

  2. Send it to your own tools

    The Signal API returns earnings signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b6abc562-2f66-ee4a-d014-6577a8d9e44d returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.

{
  "signal_id": "b6abc562-2f66-ee4a-d014-6577a8d9e44d",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-10-28T10:30:00+00:00",
  "company": {
    "name": "Boston Scientific",
    "domain": "bostonscientific.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/boston-scientific-announces-results-for-third-quarter-2026-302921450.html",
    "title": "Boston Scientific announces results for third quarter 2026",
    "ticker": "NYSE:BSX",
    "excerpt": "MARLBOROUGH, Mass. , Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported, operational 1 and organic 2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $582 million or $0.40 per share (EPS), compared to $755 million or $0.51 per share a year ago, and achieved adjusted 3 EPS of $0.73 for the period, compared to $0.75 a year ago. \"This has been a challenging year for Boston Scientific and I'm proud of how our global teams have responded, particularly to the cybersecurity incident, working with urgency and resilience to restore operations and continue supporting customers and patients,\" said Mike Mahoney, chairman and chief executive officer, Boston Scientific. \"As we move forward, I remain confident in our long-term strategy, fueled by our dedicated talent, differentiated portfolio and strong pipeline of meaningful innovation.\" Third quarter financial results and recent developments: 1. Operational net sales growth excludes the impact of foreign currency fluctuations. 2. Organic net sales growth excludes the impact of foreign currency fluctuations and net sales attributable to certain acquisitions and divestitures for which there are less than a full period of...",
    "summary": "Boston Scientific Corporation reported GAAP net income of $582 million for the third quarter of 2026.",
    "location": "Marlborough, Massachusetts, United States",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS392701/Boston-Scientific-Logo.jpg?id=OA3043165&p=facebook",
    "confidence": 0.95,
    "published_at": "2026-10-28T10:30:00Z",
    "location_data": [
      {
        "city": "Marlborough",
        "state": "Massachusetts",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "The company reported GAAP net income attributable to Boston Scientific common stockholders of $582 million or $0.40 per share (EPS), compared to $755 million or $0.51 per share a year ago, and achieved adjusted 3 EPS of $0.73 for the period, compared to $0.75 a year ago.",
    "amount_normalized": 582000000
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.